Bibhitaki (Terminalia bellirica)
Ayurvedic herb, the third constituent of Triphala, preliminary signal for lipid markers and uric acid; tradition-only as monoextract.
Why
Bibhitaki (Terminalia bellirica) completes the three Terminalia / Phyllanthus fruits of Triphala alongside Haritaki (T. chebula) and Amla (Phyllanthus emblica). As a monoextract, preliminary small RCTs report uric acid lowering and lipid effects, but most evidence emerges through the Triphala combination.
How it works
Gallic acid, ellagic acid, and tannins provide antioxidant capacity. Xanthine oxidase inhibition underlies the uric-acid signal.
Expected onset · Mild effects within weeks
How to take
Dosage
Powder: 3–6 g/day. As part of Triphala: per Triphala dosing.
Timing
Once or twice daily
On the label
Terminalia bellirica fruit powder. Quality-tested for heavy metals.
Ideal for
Adults using Triphala or interested in the constituent herbs of that formulation.
Safety
Evidence
No regulator anchor as monoextract. Tradition-only, no Cochrane review, no EMA HMPC monograph, no EFSA-authorised claim, no major-journal RCT supports a specific therapeutic effect. Inclusion reflects documented historical use in the tradition; modern clinical evidence is limited. Modern signal mostly via Triphala combination.
Tradition-only, no Cochrane review, no EMA HMPC monograph, no EFSA-authorised claim, no major-journal RCT supports a specific therapeutic effect. Inclusion reflects documented historical use in the tradition; modern clinical evidence is limited.
Where to get it
Shop Bibhitaki (Terminalia bellirica) on AmazonSponsored · As an Amazon Associate, Healicus earns from qualifying purchases.